Genomma Lab Internacional, S.A.B. de C.V. (LABB.MX) stock analysis

In our weekly check, Genomma Lab Internacional, S.A.B. de C.V. is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 19 pass, warnings: 5, red flags: 1.

About Genomma Lab Internacional, S.A.B. de C.V.

Genomma Lab Internacional, S.A.B. de C.V. is a Healthcare company (Drug Manufacturers - Specialty & Generic) based in Mexico, listed on MEX as LABB.MX.

What our checks show for LABB.MX

Red flags

Warning signs

Strengths

Similar companies

HYPE3.SA · IPN.PA · ELAN · VTRS

Questions

What grade does Genomma Lab Internacional, S.A.B. de C.V. (LABB.MX) have?

In our weekly check, Genomma Lab Internacional, S.A.B. de C.V. is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 19 pass, warnings: 5, red flags: 1. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of LABB.MX stock?

This week's biggest flags for Genomma Lab Internacional, S.A.B. de C.V.: Deep past fall, Weak interest cover, Weak revenue growth. In total 6 of 25 checks show a warning or a red flag.

What does Genomma Lab Internacional, S.A.B. de C.V. do?

Genomma Lab Internacional, S.A.B. de C.V. is a Healthcare company (Drug Manufacturers - Specialty & Generic) based in Mexico, listed on MEX as LABB.MX.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-14

Open the full analysis